Exor N.V.: Periodic Report on the Buyback Program
May 22 2023 - 2:10AM
Exor N.V.: Periodic Report on the Buyback Program
EXOR N.V. (AMS: EXO) (“Exor” or the “Company”)
announces that, under the third tranche of the share buyback
program of up to €150 million announced on 17 April 2023 (the
“third tranche”), the Company has completed the following
transactions on Euronext Amsterdam and CBOE DXE:
EURONEXT AMSTERDAM |
|
Trading Date |
Number of ordinary shares purchased |
Average price per share excluding fees (€) |
Total consideration excluding fees (€) |
15 May 2023 |
39,833 |
78.0716 |
3,109,826.20 |
16 May 2023 |
40,915 |
78.4728 |
3,210,714.94 |
17 May 2023 |
40,964 |
78.2024 |
3,203,484.38 |
18 May 2023 |
41,268 |
79.6485 |
3,286,934.56 |
19 May 2023 |
41,909 |
80.4170 |
3,370,194.66 |
TOTAL |
204,889 |
|
16,181,154.74 |
CBOE DXE |
|
Trading Date |
Number of ordinary shares purchased |
Average price per share excluding fees (€) |
Total consideration excluding fees (€) |
15 May 2023 |
22,300 |
78.1139 |
1,741,939.30 |
16 May 2023 |
21,400 |
78.4623 |
1,679,092.90 |
17 May 2023 |
21,430 |
78.2281 |
1,676,428.44 |
18 May 2023 |
21,600 |
79.6438 |
1,720,305.20 |
19 May 2023 |
22,150 |
80.4206 |
1,781,315.72 |
TOTAL |
108,880 |
|
8,599,081.56 |
After these purchases, the total invested amount
under the third tranche is approximately €66.8 million for a total
amount of 872,429 ordinary shares purchased.
As of 19 May 2023, the Company held in total
8,248,643 ordinary shares in treasury (3.53% of total ordinary
issued share capital)1.
1 This corresponds to 1.13% of the total issued
share capital including both ordinary shares and special voting
shares.
A comprehensive overview of the transactions
carried out under the share buyback program, as well as the details
of the above transactions, are available on Exor’s corporate
website under the Share Buyback section.
- Exor Press Release - W20-23 Buyback
Exor NV (TG:EYX)
Historical Stock Chart
From Dec 2024 to Jan 2025
Exor NV (TG:EYX)
Historical Stock Chart
From Jan 2024 to Jan 2025